Sponsorships and Speaking Engagements | 28 February 2019 - 01 March 2019 | Arlington, Virginia, United States

Combination Products Regulation Conference

Lina Kontos moderated the "Optimizing primary mode of action determination & process to appeal FDA decisions" panel and presented the "Regulatory update & clarification on the devices referencing drugs pathway" session at the Combination Products Regulation Conference.

The conference brought together life science industry contacts and legal professionals to discuss the unique regulatory challenges executives in combination products face when bringing products to market.

Learn More: Combination Products Regulation Conference